Tue, May 8, 2018
Mon, May 7, 2018
Fri, May 4, 2018

David Risinger Maintained (TEVA) at Hold on, May 7th, 2018

David Risinger of Morgan Stanley, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold on, May 7th, 2018.

David has made no other calls on TEVA in the last 4 months.



There are 7 other peers that have a rating on TEVA. Out of the 7 peers that are also analyzing TEVA, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gregg Gilbert of "Deutsche Bank" Maintained at Hold with Decreased Target to $18 on, Friday, February 9th, 2018
  • Tim Chiang of "BTIG" Downgraded from Strong Buy to Hold on, Thursday, January 18th, 2018


These are the ratings of the 5 analyists that currently disagree with David


  • Vamil Divan of "Credit Suisse" Maintained at Buy with Increased Target to $23 on, Monday, February 12th, 2018
  • Jason Gerberry of "B of A Securities" Maintained at Sell with Decreased Target to $16 on, Friday, February 9th, 2018
  • Ami Fadia of "Leerink Swann" Maintained at Sell with Decreased Target to $16 on, Friday, February 9th, 2018
  • David Amsellem of "Piper Sandler" Downgraded from Hold to Sell on, Friday, February 9th, 2018
  • Irina Rivkind Koffler of "Mizuho" Upgraded from Hold to Strong Buy on, Tuesday, January 9th, 2018